Photobiomodulation on Core Symptoms of Autism
ConditionAutism
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age2-6
SponsorSuez University
About this trial
This study aims to evaluate the effectiveness of photobiomodulation therapy on core symptoms in children with autism spectrum disorder. Participants will receive designed physical therapy, occupational therapy and speech program in addition to Photobiomodulation over a defined period. Out comes will be assessed using standardized clinical scales to determine improvements in social interactions, communication and behavior.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Children with autism spectrum disorders (ASD).
Their age ranged from 2 to 6 years
Disqualifiers
Children having epileptogenic seizures.
Mentally retarded children.
Children with genetic syndromes.
Trial design
Design model
Parallel
Treatments tested in this trial
Photobiomodulation
Devicenon-invasive exposure of light, typically within the red to near-infrared (\~λ = 600-1300 nm) spectrum, to elicit physiological effects across several tissue systems. The application will be transcranial with distance of 50 cm above the head. The child is in supine lying position with eyes covered with sheet
Treatment groups
30 Participants
are divided into 2 treatment groupsGroup A: Photobiomodulation GroupExperimental treatment 1 intervention
Group B: control groupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Improvement in core symptoms of autism
Assessment of changes in core autism symptoms using the Childhood Autism Rating Scale.The scale ranges from 15 to 60 , with higher scores indicating more severe autism symptoms (worse out come).
Time frame
Baseline and after 3 months of intervention2
Improvement in sensory profile
Assessment of a child's sensory processing patterns using the Sensory Profile 2. The Sensory Profile 2 is a standardized caregiver questionnaire that evaluates sensory processing across multiple domains. Scores are categorized into performance ranges (e.g., "Much Less Than Others", "Less Than Others," Just Like the Majority of Others," "More Than Others," "Much More Than Others") , with deviations from the typical range indicating greater sensory processing difficulties (worse outcome).
Time frame
Baseline and after 3 months of interventionLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: